首页> 外文期刊>Der Pharmacia Lettre >Studies on Release Performance of Proniosmes and its Tablets of BCS Class II Drug Simvastatin
【24h】

Studies on Release Performance of Proniosmes and its Tablets of BCS Class II Drug Simvastatin

机译:BCS II类药物辛伐他汀的代名词及其片剂的释放性能研究

获取原文
           

摘要

The Present investigation deals with the preparation and evaluation of proniosomes of simvastatin using non-ionic surfactant like span 60, cholesterol and maltodextrin in various proportions and evaluation of performance of prepared proniosomes in tablet dosage form. Proniosomes were prepared by slurry method. Proniosomes and tablets were evaluated for In-vitro drug release study, solid state characterization and results of dissolution study was compared with marketed formulation. Proniosomes showed very poor drug release because drug was molecularly dispersed in span 60, cholesterol and which may effect on the drug release. The prepared tablet formulation showed improvement in dissolution rate due to presence of hydrophilic carrier like a maltodextrin and other hydrophilic tablet excipients. Thus, the developed proniosomal tablet formulation of simvastatin improve dissolution rate in comparison with marketed formulation and may leads to enhancement of bioavailability of simvastatin.
机译:本研究涉及使用非离子型表面活性剂(如60跨度,胆固醇和麦芽糊精等非离子表面活性剂)以不同比例制备辛伐他汀前体,并对片剂剂型中前体的性能进行评估。通过浆液法制备原核小体。评价了proniosomes和片剂的体外药物释放研究,固态表征并将溶出研究的结果与市售制剂进行了比较。前体小体显示出非常差的药物释放,因为药物分子分散在60段胆固醇中,这可能影响药物释放。所制备的片剂制剂由于诸如麦芽糊精和其他亲水性片剂赋形剂的亲水性载体的存在而显示出溶解速率的改善。因此,与市售制剂相比,已开发的辛伐他汀的前体片剂制剂提高了溶出度,并且可能导致辛伐他汀的生物利用度提高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号